Histamine stimulates production of osteoclast differentiation factor/receptor activator of nuclear factor-κB ligand by osteoblasts

被引:31
作者
Deyama, Y
Kikuiri, T
Ohnishi, G
Feng, YG
Takeyama, S
Hatta, M
Yoshimura, Y
Suzuki, K
机构
[1] Hokkaido Univ, Grad Sch Dent Med, Dept Oral Pathobiol Sci, Div Mol Cell Pharmacol,Kita Ku, Sapporo, Hokkaido 0608586, Japan
[2] Hokkaido Univ, Grad Sch Dent Med, Dept Oral Funct Sci, Sapporo, Hokkaido 0608586, Japan
[3] Tohoku Univ, Grad Sch Dent, Dept Oral Biol, Aoba Ku, Sendai, Miyagi 9808575, Japan
关键词
histamine; histamine receptor; osteoclast; osteoblast; stromal cell; osteoclast differentiation factor/receptor activator of nuclear factor kappa B ligand (ODF/RANKL);
D O I
10.1016/S0006-291X(02)02440-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Histamine H-1, H-2, and H-3 receptors are expressed by osteoblastic MC3T3-E1 (E1) cells derived from mouse calvaria. Expression of the osteoclast differentiation factor (ODF)/receptor activator of nuclear factor-kappaB ligand (RANKL) transcript was induced in E1 cells and bone marrow stromal cells (ST2). Histamine markedly increased the steady-state level of ODF/RANKL mRNA in a dose-dependent manner. The effect of histamine on expression of ODF/RANKL mRNA by E1 cells was transient, with a peak at 6 h. Western blot analysis revealed that histamine increased production of ODF/RANKL protein by E1 cells at 12 h. In cocultures of E1 cells and mouse bone marrow cells, histamine stimulated osteoclastogenesis in the presence of 1,25-dihydroxyvitamin D-3 and this effect was blocked by preincubation with neutralizing antibody against ODF/RANKL. These results suggest that histamine regulates osteoclastogenesis, at least in part, through induction of ODF/RANKL expression by osteoblasts and bone marrow stromal cells. (C) 2002 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:240 / 246
页数:7
相关论文
共 45 条
[1]
A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function [J].
Anderson, DM ;
Maraskovsky, E ;
Billingsley, WL ;
Dougall, WC ;
Tometsko, ME ;
Roux, ER ;
Teepe, MC ;
DuBose, RF ;
Cosman, D ;
Galibert, L .
NATURE, 1997, 390 (6656) :175-179
[2]
AOI R, 1989, IMMUNOLOGY, V66, P219
[3]
BEER DJ, 1987, CRC CR REV IMMUNOL, V7, P55
[4]
Osteoblast maturation suppressed osteoclastogenesis in coculture with bone marrow cells [J].
Deyama, Y ;
Takeyama, S ;
Koshikawa, M ;
Shirai, Y ;
Yoshimura, Y ;
Nishikata, M ;
Suzuki, K ;
Matsumoto, A .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 274 (01) :249-254
[5]
Dobigny C, 1997, J CELL PHYSIOL, V173, P10, DOI 10.1002/(SICI)1097-4652(199710)173:1<10::AID-JCP2>3.0.CO
[6]
2-M
[7]
PARTIAL INHIBITION OF BONE-RESORPTION BY DISODIUM-CROMOGLYCATE IN A SYNCHRONIZED MODEL OF BONE REMODELING [J].
DOBIGNY, C ;
SAFFAR, JL .
AGENTS AND ACTIONS, 1991, 33 (3-4) :326-329
[8]
RANK is essential for osteoclast and lymph node development [J].
Dougall, WC ;
Glaccum, M ;
Charrier, K ;
Rohrbach, K ;
Brasel, K ;
De Smedt, T ;
Daro, E ;
Smith, J ;
Tometsko, ME ;
Maliszewski, CR ;
Armstrong, A ;
Shen, V ;
Bain, S ;
Cosman, D ;
Anderson, D ;
Morrissey, PJ ;
Peschon, JJ ;
Schuh, J .
GENES & DEVELOPMENT, 1999, 13 (18) :2412-2424
[10]
FALUS A, 1993, IMMUNOLOGY, V78, P193